Download slides from our global impact of COVID-19 on SRH and rights, which took place online on 24 June 2020.
Filter documents Clear search
Joint BMS / FSRH / RCGP / RCOG framework for restoration of menopause services in response to COVID-19
The objective of this joint document produced by the British Menopause Society (BMS), the Royal College of Obstetricians and Gynaecologists (RCOG), the Royal College of General Practitioners (RCGP) and the Faculty of Sexual and Reproductive Healthcare (FSRH) is to provide guidance to clinical practitioners on the resumption and running of menopause services in the next phase of restoration of planned clinical services.
Download the slides from the webinar - 10 June 2020
Full Question: Regarding self administration at home of sayana press for someone who was starting an injectable for the first time - how safe is this (in relation to anaphylaxis) to be done at home for women who have not already had DMPA or sayana (bearing in mind anaphylaxis can sometimes only manifest itself after the second injection)?
Full Question: Please can you explain why it is OK to use a Nexplanon® for 4 years and Mirena® for 6 years during Covid-19 but not under normal circumstances?
Suggested approach - Restoration of SRH Services during Covid-19
This guidance on restoration of SRH services is aimed at decision-makers, commissioners, service managers and healthcare professionals. It was developed in consultation with FSRH’s Scotland, Wales and Northern Ireland Committees. It provides recommendations on which services should be prioritised during restoration. It also outlines what has worked well during strict lockdown and should remain in place beyond the pandemic; for instance, the need for a variety of modalities of consultation to meet the SRH care needs of all, including the most vulnerable.
This FSRH guidance is for health care professionals using Public Health England's PPE guidance within sexual and reproductive health services.
Full question: For women starting a CHC the first year seems to be when the highest risk of VTE. Is there some caution we should be taking with starting CHC at this current time when there is an increased risk of contracting Covid 19? Should we be more careful in those women with a higher BMI who may not be contraindicated to CHC? In smokers? Would it also be more of concern in those women who are shielding who may have more of a concern that covid may be more severe in them?
Rolling Covid-19 members survey as of 07 May 2020